# October Capital

> October Capital is a VC fund in Kansas City backing Biotechnology and Medical. See 13 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Kansas City, United States
- Total investments: 13
- Last investment: Nov 2023
- Lead investor: 31%
- Last updated: Aug 2026
- Website: http://www.octobercapital.com

October Capital is a family investment firm that finances early and growth stage ventures.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 31% |
| Medical | 3 | 23% |
| Health Care | 3 | 23% |
| Manufacturing | 3 | 23% |
| Life Science | 2 | 15% |

29 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 4 | 31% |
| Series A | 2 | 15% |
| Series C | 2 | 15% |
| Funding Round | 2 | 15% |
| Series E | 1 | 8% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 10 | 77% |
| United States | 3 | 23% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Bang Er Orthopedic | Zhejiang Boner Medical Investment Management Co., Ltd. is a well-known professional hospital investment operator in the Yangtze River Delta, featuring major orthopaedics and rehabilitation. | $109.8M | Series E | Nov 09, 2023 |  |
| Super Years | Super Years is a gene technology company that focuses on the research, development, and manufacturing of high-end life science instruments. | $8.2M | Series A | Sep 24, 2023 |  |
| Epintek | Epintek is a one-stop service platform for medical equipment. |  | Series C | Aug 28, 2023 |  |
| Bostal Drug Delivery | Bostal Drug Delivery develops and manufactures drug preparation products for new drug delivery systems. The company provides pharmaceutical preparation technology platforms to develop innovative drugs, improve new drugs, and high-end generic drugs. It also offers preparation products technical development services for pharmaceutical companies.Thecompany was founded in 2013 and is headquartered in Guangzhou, Guangdong. |  | Series B | Aug 18, 2023 |  |
| Nuclei System Technology | A notable feature of the RISC-V architecture is its open scalability to facilitate the special needs of specialized areas. It is embodied in the instruction code space and the predefined Custom command, which is convenient for specific functions such as security or intelligent acceleration under the unified development model to make the productmore competitive. Nuclei System Technology provides customers with RISC-V related training services with the most professional technology, instruction set expansion and acceleration module design services based on core RISC-V processor IP, and dedicated high performance and low power processor design services. |  | Venture - Series Unknown | Aug 01, 2023 |  |
| Anjielai Technology | Anjielai Technology is a developer of artificial intelligence exoskeleton robots. |  | Private Equity | Jan 01, 2023 |  |
| Atech Automotive Electronics | Atech Automotive Electronics is a company that designs, develops, manufactures and sells various automotive electronic products | $69M | Series C | Nov 08, 2022 |  |
| Baiying Bio | Baiying Bio offers economic recombinant protein and antibody reagents and is a CRO vendor for life science researchers and biopharma companies. They provide services including HTP recombinant antibody and VHH production, bispecific antibody production, antibody humanization, VHH library generation, hybridoma sequencing, protein expression inmammalian cells, large-scale antibody production, and more. They delivered tens of thousands of recombinant antibodies to customers. | $72.6M | Series B | Aug 31, 2022 |  |
| Biointron | Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents. The company was founded in 2012 and is headquartered in Shanghai, China. | $72.6M | Series B | Aug 31, 2022 |  |
| Ling Yan Technology | Ling Yan Technology offers integrated information and communication technology (ICT) solutions. |  | Series A | Oct 22, 2021 |  |

10 of 13 investments shown.

## Co-investors
- [ALAN AMC](https://shizune.co/investors/profile/alan-amc) — VC Fund, 2 deals together
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 2 deals together
- [Binfu Capital](https://shizune.co/investors/profile/binfu-capital) — VC Fund, 2 deals together
- [China Fortune-Innovation Capital](https://shizune.co/investors/profile/china-fortunr-innovation-capital) — VC Fund, 2 deals together
- [Co-Stone Venture Capital](https://shizune.co/investors/profile/co-stone-capital) — VC Fund, 2 deals together
- [CS Capital](https://shizune.co/investors/profile/cs-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)

## FAQ

### What does October Capital invest in?

October Capital invests primarily in Biotechnology, Medical and Health Care startups, most often at Series B and Series A stage. Most of the 13 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did October Capital last invest?

The most recent investment recorded for October Capital closed in Nov 2023. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co